1. The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer
   Eva Sodja et al, 2016, Radiology and Oncology CrossRef
2. Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer
   Johanna Samulin Erdem et al, 2016, BMC Cancer CrossRef
3. Functional characterization of SOX2 as an anticancer target
   Shizhen Zhang et al, 2020, Signal Transduction and Targeted Therapy CrossRef
4. Expression and significance of SOX2 in non-small cell lung carcinoma
   Jie Ying et al, 2016, Oncology Letters CrossRef
5. Quantification of serum SOX2 DNA with FQ-PCR potentially provides a diagnostic biomarker for lung cancer
   Yanfeng Wu et al, 2013, Medical Oncology CrossRef
6. Application value of spiral CT combined with autoantibody tests in the diagnosis of early lung cancer
   Zhihui Dong et al, 2024, Journal of Radiation Research and Applied Sciences CrossRef
7. Changes in the number of copies of genetic loci in gastric cancer
   O. I. Kit et al, 2015, Molecular Biology CrossRef
8. Association of SOX2 and Nestin DNA amplification and protein expression with clinical features and overall survival in non-small cell lung cancer: A systematic review and meta-analysis
   Qingbao Li et al, 2016, Oncotarget CrossRef
9. The Prognostic Value of SOX2 Expression in Non-Small Cell Lung Cancer: A Meta-Analysis
   Yansu Chen et al, 2013, PLoS ONE CrossRef
10. DNA copy number gains in malignant pleural mesothelioma
    MASASHI FURUKAWA et al, 2015, Oncology Letters CrossRef